Examination of an experimental drug for children with Multiple Osteochondromas (MO).

  • This study 
    Investigates the effectiveness and safety of a new drug (palovarotene) in patients with HME-MO.
  • Principal investigator
    A.L. van der Zwan, MD
  • Contact Joint Research
    Amanda Klaassen
  • This study is in collaboration with 
    Multiple hospitals in the Netherlands.
  • For this study 
    Inclusion has stopped.
  • More information
    Visit the website